Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease.
The prognostic utility of the relative lymphocyte concentration was tested in a population-based study of chronic coronary artery disease. This inexpensive, readily available test was found to be significantly related to survival (p = 0.03) in 211 patients followed for a mean of 45 months.
Ommen
S R
SR
Mayo Clinic and Mayo Foundation, Rochester, Minnesota 55905, USA.
Gibbons
R J
RJ
Hodge
D O
DO
Thomson
S P
SP
D000368:Aged; D015415:Biomarkers; D015331:Cohort Studies; D003327:Coronary Disease / Q000097:blood* / Q000401:mortality; D005260:Female; D006801:Humans; D018655:Lymphocyte Count; D008297:Male; D008875:Middle Aged; D008910:Minnesota / Q000453:epidemiology; D011379:Prognosis; D012189:Retrospective Studies; D016019:Survival Analysis; D013997:Time Factors
D015415:Biomarkers